Abstract:Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous group of mostly incurable hematologic malignancies driven by transformed stem cells (leukemic stem cells, LSC) endowed with enhanced self-renewal capacity and blocked myeloid differentiation. Insights into pathways of LSC maintenance will provide key targets for curative therapies. We have previously shown that chaperone-mediated autophagy (CMA) is essential for metabolic adaptation in HSC to regenerative stress (Dong et al., Nature 2021). To test the relevance of CMA in LSC, we developed new mouse models of AML with concomitant CMA deficiency through conditionally deleting (Vav-iCre driven) Lysosome-associated membrane protein 2 (Lamp2a, L2A) which is specific and rate-limiting for this autophagy pathway. We characterized self-renewal and myeloid differentiation potential of leukemia cells upon L2A deletion by gold-standard serial ex vivo colony assays and in vivo bone marrow transplantation assays. Our data thus far have revealed that CMA blockade causes compromised ex vivo self-renewal of LSC and significantly prolongs survival of recipients upon adoptive cell transfer compared to L2AWT controls, consistent with compromised LSC maintenance. Moreover, CMA deficient LSC presented with significantly increased myeloid differentiation compared to CMA competent LSC, suggesting that CMA impacts molecular pathways that favor self-renewal over differentiation commitment. We are currently building precise humanized models and employ degron-mediated ablation of L2A to test the consequences of CMA ablation in human AML. If successful, our study will provide exciting preclinical rationales for the testing of CMA inhibitors for eradication of LSC, particularly alongside current mainstay therapies, as a novel and potential curative option for patients with myeloid malignancies. Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous group of mostly incurable hematologic malignancies driven by transformed stem cells (leukemic stem cells, LSC) endowed with enhanced self-renewal capacity and blocked myeloid differentiation. Insights into pathways of LSC maintenance will provide key targets for curative therapies. We have previously shown that chaperone-mediated autophagy (CMA) is essential for metabolic adaptation in HSC to regenerative stress (Dong et al., Nature 2021). To test the relevance of CMA in LSC, we developed new mouse models of AML with concomitant CMA deficiency through conditionally deleting (Vav-iCre driven) Lysosome-associated membrane protein 2 (Lamp2a, L2A) which is specific and rate-limiting for this autophagy pathway. We characterized self-renewal and myeloid differentiation potential of leukemia cells upon L2A deletion by gold-standard serial ex vivo colony assays and in vivo bone marrow transplantation assays. Our data thus far have revealed that CMA blockade causes compromised ex vivo self-renewal of LSC and significantly prolongs survival of recipients upon adoptive cell transfer compared to L2AWT controls, consistent with compromised LSC maintenance. Moreover, CMA deficient LSC presented with significantly increased myeloid differentiation compared to CMA competent LSC, suggesting that CMA impacts molecular pathways that favor self-renewal over differentiation commitment. We are currently building precise humanized models and employ degron-mediated ablation of L2A to test the consequences of CMA ablation in human AML. If successful, our study will provide exciting preclinical rationales for the testing of CMA inhibitors for eradication of LSC, particularly alongside current mainstay therapies, as a novel and potential curative option for patients with myeloid malignancies.

Chaperone-mediated autophagy sustains haematopoietic stem-cell function

Amino Acid Transporter X is Required for Hematopoietic Stem Cell Maintenance Through Regulating Specific Amino Acids Level

Chaperone‐mediated autophagy protects the bone formation from excessive inflammation through <scp>PI3K/AKT/GSK3β</scp>/β‐catenin pathway

Calorie restriction and calorie-restriction mimetics activate chaperone-mediated autophagy

Chaperone-mediated autophagy modulates regulatory T cell differentiation and function

3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS

The coming of age of chaperone-mediated autophagy

The Role of Chaperone-Mediated Autophagy in Tissue Homeostasis and Disease Pathogenesis

Restoration of LAMP2A expression in old mice leads to changes in the T cell compartment that support improved immune function

Chaperone-Mediated Autophagy Regulates Hypoxic Pathology in Cardiomyocytes

Chaperone-mediated autophagy protects against atherosclerosis

Maintenance of Hematopoietic Stem Cells Through Regulation of Wnt and Mtor Pathways

Selective protein degradation through chaperone‐mediated autophagy: Implications for cellular homeostasis and disease (Review)

Intrinsic role of chaperone-mediated autophagy in cancer stem cell maintenance

Autophagy‐Sirt3 axis decelerates hematopoietic aging

Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis

Age-related defects in autophagy alter the secretion of paracrine factors from bone marrow mononuclear cells

Autophagy regulates the cell cycle of murine HSPCs in a nutrient-dependent manner.

3128 – HYALURONIC ACID- GPRC5C SIGNALLING PROMOTES DORMANCY IN HEMATOPOIETIC STEM CELLS

Inflammation-induced inhibition of chaperone-mediated autophagy maintains the immunosuppressive function of murine mesenchymal stromal cells

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells